Cabozantinib most effective treatment for metastatic papillary kidney cancer
WHO experts want ‘more data’ from China on possible early Covid cases
13 February 2021Israeli study shows Pfizer vaccine 94 percent effective
14 February 2021Cabozantinib most effective treatment for metastatic papillary kidney cancer
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer—findings expected to change medical practice.
